Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

NVP Healthcare

Status and phase: Withdrawn; Phase 1

Conditions: Healthy

Treatments: Drug: NVP-1203; Drug: Eperisone SR tab. + and Airtal tab.

Study type: Interventional

Funder types: Industry

Identifiers

NCT02289274

NVP-1203-BE

Details and patient eligibility

About

The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.

Full description

aceclofenac and eperisone(low back pain)

Sex: Male

Ages: 19 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male volunteers, age between 19 and 45
• BMI of >19kg/m2 and <28kg/m2 subject
• Informed of the investigational nature of this study and voluntarily agree to participate in this study

Exclusion criteria

• Use of any prescription medication within 14 days prior to Day 1
• Use of any medication within 7 days prior to Day 1

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

NVP-1203

Experimental group

Description:

NVP-1203

Treatment:

Drug: NVP-1203

Eperisone SR tab. + and Airtal tab.

Active Comparator group

Description:

Eperisone HCl and aceclofenac

Treatment:

Drug: Eperisone SR tab. + and Airtal tab.